© 1997 by European Society of Cardiology
Copyright © 1997, European Society of Cardiology
Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase
Children's Hospital Medical Center, Division of Critical Care, 3333 Burnet Avenue, Cincinnati OH 45229, USA
* Corresponding author. Tel.: +1-513-636-8714; fax: +1-513-636-4892; e-mail: csaba.szabo@chmcc.org
Objective: Peroxynitrite and hydroxyl radical, reactive oxidants produced during reperfusion, are potent triggers of DNA single strand breakage. DNA injury triggers the activation of the nuclear enzyme poly (ADP-ribose) synthetase (PARS), which contributes to cellular energetic depletion. Using 3-aminobenzamide, an inhibitor of PARS, we investigated the role of PARS in the pathogenesis of myocardial reperfusion injury in a rat model. Methods and results: Occlusion of the left main coronary artery (one hour) followed by reperfusion (one hour) in the anesthetized rat caused severe cardiac necrosis, neutrophil infiltration, and increased plasma creatine phosphokinase activity. There was significant peroxynitrite production during reperfusion, as indicated by a massive increase in nitrotyrosine in the necrotic myocardium. Reperfusion was also associated with a significant loss of myocardial ATP. In vivo administration of the PARS inhibitor 3-aminobenzamide (10 mg/kg i.v.) to rats subjected to myocardial ischemia and reperfusion, reduced myocardial infarct size and blunted the increase in plasma creatine phosphokinase activity and myeloperoxidase activity in infarcted hearts. In addition, 3-aminobenzamide partially preserved the myocardial ATP levels. In vitro, pharmacological inhibition of PARS also ameliorated peroxynitrite-induced cytotoxicity in rat cardiac myocytes and human endothelial cells. Conclusion: 3-aminobenzamide has significant protective effects in myocardial reperfusion injury. We hypothesize that activation of PARS activation plays a role in the pathophysiology of acute myocardial infarction.
KEYWORDS Peroxynitrite; DNA damage; Nitrotyrosine; Nitric oxide; Oxygen radicals
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K.-S. Oh, S. Lee, K. Y. Yi, H. W. Seo, H.-N. Koo, and B. H. Lee A Novel and Orally Active Poly(ADP-Ribose) Polymerase Inhibitor, KR-33889 [2-[Methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic Acid Amide], Attenuates Injury in in Vitro Model of Cell Death and in Vivo Model of Cardiac Ischemia J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 10 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Eltze, R. Boer, T. Wagner, S. Weinbrenner, M. C. McDonald, C. Thiemermann, A. Burkle, and T. Klein Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors Mol. Pharmacol., December 1, 2008; 74(6): 1587 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yau, P. Molnar, M. C. Moon, S. Buhay, J. P. Werner, K. Molnar, L. Saward, D. Del Rizzo, and P. Zahradka meta-Iodobenzylguanidine, an Inhibitor of Arginine-Dependent Mono(ADP-ribosyl)ation, Prevents Neointimal Hyperplasia J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 717 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Chowdhry, H. A. Vohra, and M. Galinanes Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 124 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Esposito, E. Mazzon, C. Muia, R. Meli, E. Sessa, and S. Cuzzocrea Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-{alpha} J. Leukoc. Biol., April 1, 2007; 81(4): 1032 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Jo, M. H. Rosner, and M. D. Okusa Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven't Worked and What Is on the Horizon Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 356 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Z. Zhou, R. A. Swanson, U. Simonis, X. Ma, G. Cecchini, and M. O. Gray Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H714 - H723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szabo, N. Stumpf, T. Radovits, K. Sonnenberg, D. Gero, S. Hagl, C. Szabo, and S. Bahrle Effects of inosine on reperfusion injury after heart transplantation. Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nagata, T. Horiguchi, K. Enzan, T. Nishikawa, and K. Suzuki Inhibition of Poly (ADP-ribose) Synthetase Improves Pulmonary Arterial Endothelium-Dependent Relaxation After Ischemic-Reperfusion Injury of Splanchnic Artery in Rats Anesth. Analg., December 1, 2005; 101(6): 1799 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Palfi, A. Toth, G. Kulcsar, K. Hanto, P. Deres, E. Bartha, R. Halmosi, E. Szabados, L. Czopf, T. Kalai, et al. The Role of Akt and Mitogen-Activated Protein Kinase Systems in the Protective Effect of Poly(ADP-Ribose) Polymerase Inhibition in Langendorff Perfused and in Isoproterenol-Damaged Rat Hearts J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 273 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Genovese, E. Mazzon, R. D. Paola, C. Muia, M. D. Threadgill, A. P. Caputi, C. Thiemermann, and S. Cuzzocrea Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and the Development of Bleomycin-Induced Lung Injury J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S.A. Patel, U. Cortes, R. Di Poala, E. Mazzon, H. Mota-Filipe, S. Cuzzocrea, Z.-Q. Wang, and C. Thiemermann Mice Lacking the 110-kD Isoform of Poly(ADP-Ribose) Glycohydrolase Are Protected against Renal Ischemia/Reperfusion Injury J. Am. Soc. Nephrol., March 1, 2005; 16(3): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szabo, P. Soos, U. Heger, C. Flechtenmacher, S. Bahrle, Z. Zsengeller, C. Szabo, and S. Hagl Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation Eur. J. Cardiothorac. Surg., February 1, 2005; 27(2): 226 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Suzuki, E. Masini, C. Mazzocca, S. Cuzzocrea, A. Ciampa, H. Suzuki, and D. Bani Inhibition of Poly(ADP-Ribose) Polymerase Prevents Allergen-Induced Asthma-Like Reaction in Sensitized Guinea Pigs J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1241 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cuzzocrea, G. Nocentini, R. Di Paola, E. Mazzon, S. Ronchetti, T. Genovese, C. Muia, A. P. Caputi, and C. Riccardi Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock J. Leukoc. Biol., November 1, 2004; 76(5): 933 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamazaki, S. Miwa, K. Ueda, S. Tanaka, S. Toyokuni, O. Unimonh, K. Nishimura, and M. Komeda Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Xiao, M. Chen, Z. Zsengeller, and C. Szabo Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szabo, P. Soos, S. Bahrle, Z. Zsengeller, C. Flechtenmacher, S. Hagl, and C. Szabo Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 825 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zingarelli, P. W. Hake, M. O'Connor, A. Denenberg, H. R. Wong, S. Kong, and B. J. Aronow Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1 Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1408 - H1415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szabo, L. Liaudet, S. Hagl, and C. Szabo Poly(ADP-ribose) polymerase activation in the reperfused myocardium Cardiovasc Res, February 15, 2004; 61(3): 471 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szabo, V. Buhmann, T. Andrasi, N. Stumpf, S. Bahrle, V. Kekesi, S. Hagl, C. Szabo, and A. Juhasz-Nagy Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 651 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Padanilam Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis Am J Physiol Renal Physiol, April 1, 2003; 284(4): F608 - F627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.a. Pacher, L. Liaudet, J. G. Mabley, K. Komjati, and C. Szabo Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure J. Am. Coll. Cardiol., September 4, 2002; 40(5): 1006 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Virag and C. Szabo The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors Pharmacol. Rev., September 1, 2002; 54(3): 375 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Khandoga, G. Enders, P. Biberthaler, and F. Krombach Poly(ADP-ribose) polymerase triggers the microvascular mechanisms of hepatic ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G553 - G560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pacher, L. Liaudet, P. Bai, L. Virag, J. G. Mabley, G. Hasko, and C. Szabo Activation of Poly(ADP-Ribose) Polymerase Contributes to Development of Doxorubicin-Induced Heart Failure J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 862 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage FASEB J, March 1, 2002; 16(3): 327 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Faro, Y. Toyoda, J. D. McCully, P. Jagtap, E. Szabo, L. Virag, C. Bianchi, S. Levitsky, C. Szabo, and F. W. Sellke Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor Ann. Thorac. Surg., February 1, 2002; 73(2): 575 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, L. Liaudet, F. G. Soriano, J. G. Mabley, E. Szabo, and C. Szabo The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes Diabetes, February 1, 2002; 51(2): 514 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Watts, R. M. Grattan II, B. S. Whitlow, and J. A. Kline Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G498 - G506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Halmosi, Z. Berente, E. Osz, K. Toth, P. Literati-Nagy, and B. Sumegi Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System Mol. Pharmacol., June 1, 2001; 59(6): 1497 - 1505. [Abstract] [Full Text]
|
|
|
|
 |
|
 S Cuzzocrea, M C McDonald, E Mazzon, H Mota-Filipe, T Centorrino, M L Terranova, A Ciccolo, D Britti, A P Caputi, and C Thiemermann Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat Gut, April 1, 2001; 48(4): 478 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cuzzocrea, D. P. Riley, A. P. Caputi, and D. Salvemini Antioxidant Therapy: A New Pharmacological Approach in Shock, Inflammation, and Ischemia/Reperfusion Injury Pharmacol. Rev., March 1, 2001; 53(1): 135 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B Jijon, T. Churchill, D. Malfair, A. Wessler, L. D Jewell, H. G Parsons, and K. L Madsen Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis Am J Physiol Gastrointest Liver Physiol, September 1, 2000; 279(3): G641 - G651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cuzzocrea, E. Mazzon, G. Costantino, I. Serraino, A. De Sarro, and A. P. Caputi Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury Cardiovasc Res, August 18, 2000; 47(3): 537 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. CUZZOCREA, T. P. MISKO, G. COSTANTINO, E. MAZZON, A. MICALI, A. P. CAPUTI, H. MACARTHUR, and D. SALVEMINI Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion FASEB J, June 1, 2000; 14(9): 1061 - 1072. [Abstract] [Full Text]
|
|
|
|
|
|
P. K. CHATTERJEE, K. ZACHAROWSKI, S. CUZZOCREA, M. OTTO, and C. THIEMERMANN Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo FASEB J, April 1, 2000; 14(5): 641 - 651. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. STERN, A. SALZMAN, R. T. COTTON, and B. ZINGARELLI Protective Effect of 3-Aminobenzamide, an Inhibitor of Poly (ADP-Ribose) Synthetase, against Laryngeal Injury in Rats Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1743 - 1749. [Abstract] [Full Text]
|
|
|
|
|
|
L. Virág, G. S. Scott, P. Antal-Szalmás, M. O'Connor, H. Ohshima, and C. Szabó Requirement of Intracellular Calcium Mobilization for Peroxynitrite-Induced Poly(ADP-Ribose) Synthetase Activation and Cytotoxicity Mol. Pharmacol., October 1, 1999; 56(4): 824 - 833. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. J. Pulido, B. D. Shames, C. H. Selzman, H. A. Barton, A. Banerjee, D. D. Bensard, and R. C. McIntyre Jr. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L769 - L776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bowes, M. C. McDonald, J. Piper, and C. Thiemermann Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress Cardiovasc Res, January 1, 1999; 41(1): 126 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zingarelli, A. L. Salzman, and C. Szabo Genetic Disruption of Poly (ADP-Ribose) Synthetase Inhibits the Expression of P-Selectin and Intercellular Adhesion Molecule-1 in Myocardial Ischemia/Reperfusion Injury Circ. Res., July 13, 1998; 83(1): 85 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Szabo, S. Bahrle, N. Stumpf, K. Sonnenberg, E. Szabo, P. Pacher, T. Csont, R. Schulz, T. J. Dengler, L. Liaudet, et al. Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation Circ. Res., January 11, 2002; 90(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|